CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters SUMMIT, N.J., Feb. 6, 2008 (PRIME NEWSWIRE) -- CorMedix Inc., a New York-area biopharmaceutical company, announced today that it had acquired exclusive worldwide rights to develop, manufacture and...

CorMedix Enlists World-Class Panel to Advise On Cardiorenal Medicine SUMMIT, N.J., Jan. 8, 2008 (PRIME NEWSWIRE) -- CorMedix Inc., a biopharmaceutical company, today announced that it had established an advisory panel of world-renowned physicians with special expertise...

CorMedix Studies Show That Removing 'Toxic' Iron Could Slow Progression of Chronic Kidney Disease SAN FRANCISCO, Nov. 2, 2007 (PRIME NEWSWIRE) -- In the first two proof-of-concept studies in humans, CorMedix Inc. has shown that deferiprone -- an iron-trapping drug -- could become a major new...